NCT03164590View on ClinicalTrials.gov

Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

September 1, 2018

Conditions
Endometrial Adenocarcinoma
Interventions
DRUG

Ketamine

patients receive local anesthetic wound infiltration with 1 mg /kg ketamine

DRUG

dexmedetomidine

patients receive local anesthetic wound infiltration with 1µg/kg dexmedetomidine

DRUG

bupivacaine

patients receive local anesthetic wound infiltration with bupivacaine 0.5 % diluted in 20 ml saline

Trial Locations (1)

171516

South Egypt Cancer instIitute, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03164590 - Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines | Biotech Hunter | Biotech Hunter